Hip Implants Market Size, Revenue Share, Drivers & Trends Analysis Till 2027

 


According to MRFR analysis, Hip Implants Market is expected to register a CAGR of 4.1% during the forecast period and is expected to reach USD 9,300 Million by 2025.

Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, which is also known as hip prosthesis. Hip replacement surgery can be performed as a hemi (half) replacement or total replacement. The growth of the global hip implants market is driven by various factors, such as the introduction of custom-made implants and the growing geriatric population. Increased product launches, mergers, acquisitions, and partnerships of the major players of the market attributed to the growth of the market. However, stringent government regulations on all-metal hip implants and an increase in the number of product recalls are projected to hamper the growth of the global hip implants market.

Several market players currently dominate the global hip implants market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For example, in May 2018, DePuy Synthes acquired Medical Enterprises Distribution, LLC, with its automated surgical impactor for hip replacement. Through this acquisition, the former developed and broadened the surgical impactor technology for a wide range of orthopedic surgery procedures.

Segmentation

The global hip implants market has been segmented based on the product, material, and end user.

The market, based on product, has been divided into total hip replacement implants and partial hip replacement implants. Total hip replacement segment is further segmented into fixed-bearing hip implants and mobile-bearing total hip implants. The partial hip implants segment has been further bifurcated into hip resurfacing implants and revision hip replacement implants.

The total hip replacement implants segment is likely to be the largest during the review period due to the increasing geriatric population and prevalence of hip-related disorders. The partial hip replacement implants devices segment is predicted to be the fastest-growing due to less deterioration and friction than all-metal hip implants.

Many players have introduced in the total hip replacement market with advanced technologies. For instance, in March 2019, DJO launched ADAPTABLE, a sterile surgeon-controlled leg and retractor holder, which is designed for the direct anterior approach for total hip arthroplasty.

The global hip implants market has been segregated, based on material, into metal-on-polyethylene, metal-on-metal, ceramic-on-metal, ceramic-on-polyethylene, and ceramic-on-ceramic.

The metal-on-polyethylene segment is expected to account for the largest share of the market attributing to the rising demand of polymer as it reduces the side-effects in comparison to regular hip implants. The ceramic-on-metal segment is touted to grow at an exponential rate due to less friction and deterioration than the metal hip implants. 

The end users in the market are hospitals, orthopedic clinics, ambulatory surgical centers, and others.

The hospitals segment accounts for the largest share of the market as the availability of various facilities and treatment options in the hospitals. The orthopedic clinics segment is touted to grow at an exponential rate due to the presence of availability of skilled surgeons and well-developed infrastructure.

Key Players

Some of the key players in the global hip implants market are Corin (UK), DJO Global, Inc. (US), OMNILife science, Inc. (US), MicroPort Scientific Corporation (China), Stryker Corporation (UK), Zimmer Biomet Holdings, Inc. (US), Smith & Nephew PLC (UK), Exactech, Inc. (US), B. Braun Melsungen AG (Germany), and Aesculap Implant Systems, LLC (US).

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The hip implants market in the Americas has further been branched into North America and Latin America, with the North American market being divided into the US and Canada. The European hip implants market has been categorized as Western Europe and Eastern Europe. The Western European market has been further classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hip implants market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the growing geriatric population and increasing demand for hip replacement surgeries, the market in Asia-Pacific is expected to be the fastest-growing.

The hip implants market in the Middle East & Africa has been divided into the Middle East and Africa.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

 

Comments

Post a Comment

Popular posts from this blog

Doxorubicin Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
Doxorubicin is a type of chemotherapy medicine called an anthracycline. It is used to reduce or diminish the growth of cancer cells by blocking an enzyme called topo isomerase. Factors that are propelling the growth of the  doxorubicin market  are surge in geriatric population, rising prevalence of different types of cancer, increasing awareness for cancer treatment. According to the International Federation of Pharmaceutical Manufacturers & Associations, global pharmaceutical industry has spent more than USD 149.8 billion on pharmaceutical Research and development activities. The various side effects, cost containment policies by various governments, stringent regulatory environment for product approval, are likely to hinder market growth during the forecast period. Regional Analysis The American market is expected to dominate the global doxorubicin market during the forecast period due to the presence of major manufacturers, increase in number of cancer cases, awareness ...
Read more

Chromatography Software Market Size, Revenue Analysis, Industry Outlook, Forecast Till 2030

Image
According to MRFR analysis, the global  Chromatography Software Market  is expected to register a CAGR of ~8.1% from 2022 to 2030 and hold a value of USD 15,330 million by 2030. Chromatography software is the gadget that allows chromatography-based analysis. This software system organizes and manages data from chromatography instruments, records and processes it, and generates chromatograms and reports. Data processing, instrument control, and database management are automated using this chromatography data software. Chromatography informatics solutions are available in various formats, from integrated to automated independent software platforms. These tools are employed in multiple sectors, including materials science, drug development, and forensics. The growing demand for chromatography applications in different fields, surge in the utilization of chromatography techniques in R&D activities across various industries such as the pharmaceutical industry and increasing tec...
Read more

Orthokeratology Lens Market Revenue Trends, Company Profiles, Revenue Share Analysis Till 2030

Image
The   Orthokeratology Lens Market   is expected to reach USD 3,900.8 Million by 2030 at 7.8% CAGR during the forecast period 2022-2030. Orthokeratology is also known as ortho-k, corneal refractive therapy (CRT), and overnight vision correction therapy. In the orthokeratology therapy, rigid gas permeable contact lenses are worn overnight that reshapes the curvature of the cornea to improve object visibility. The use of ortho-k lenses eliminates the need for daytime contact lenses or glasses and improves vision. The increasing advancements in the field of ophthalmology over the past couple of decades, low cost compared to laser-assisted in situ keratomileuses (LASIK) treatment is anticipated to drive the market growth. However, the risk associated with orthokeratology and availability of alternative treatment methods is likely to hamper the market growth. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/8218 Segment Analysis The global ortho...
Read more